Association of Molecular Senescence Markers in Late-Life Depression With Clinical Characteristics and Treatment Outcome
Dots indicate each individual included in the analysis; shaded area indicates 95% CI for the linear trend; line indicates linear trend. CIRS-G indicates Cumulative Illness Rating Scale–Geriatrics.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Diniz BS, Mulsant BH, Reynolds CF, et al. Association of Molecular Senescence Markers in Late-Life Depression With Clinical Characteristics and Treatment Outcome. JAMA Netw Open. 2022;5(6):e2219678. doi:10.1001/jamanetworkopen.2022.19678
Question Are markers associated with the senescence-associated secretory phenotype (SASP) associated with treatment remission in older adults with major depressive episode?
